HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Rapid release fentanyl administration forms. Comments of the Working Group on Tumor Pain of the German Pain Society].

Abstract
The spectrum of indications for rapid release fentanyl preparations is controversial. For this reason the Working Group on Tumor Pain will formulate comments on how to deal with these substances. Breakthrough pain should receive individualized therapy; therefore, the use of opioids of various galenic formulations seems to be advisable. New rapid release fentanyl preparations are suitable for alleviating spontaneous breakthrough pain in tumor patients due to a rapid but short-acting effect. However, a prior optimization of the analgesic basis medication is absolutely necessary. Uncontrolled prescription for non-cancer pain must be criticized due to the problem of addiction. The medical profession should be informed about the benefits of rapid release fentanyl preparations but must also be made aware of the risk of a rapid development of addiction and tolerance. A self-commitment of the pharmaceutical industry to waive advertising for the dangerous off-label use would be desirable. In the opinion of the Working Group on Tumor Pain the use of fentanyl should be openly discussed and further scientific investigations are imperative with the aim of formulating clear recommendations.
AuthorsS Wirz, C H R Wiese, M Zimmermann, U Junker, E Heuser-Grannemann, M Schenk
JournalSchmerz (Berlin, Germany) (Schmerz) Vol. 27 Issue 1 Pg. 76-80 (Feb 2013) ISSN: 1432-2129 [Electronic] Germany
Vernacular TitleSchnell freisetzende Fentanylapplikationsformen. Stellungnahme des Arbeitskreises Tumorschmerz der Deutschen Schmerzgesellschaft.
PMID23377349 (Publication Type: Journal Article)
Chemical References
  • Analgesics, Opioid
  • Fentanyl
Topics
  • Advertising
  • Analgesics, Opioid (administration & dosage, adverse effects, pharmacokinetics)
  • Breakthrough Pain (blood, drug therapy)
  • Drug Industry
  • Drug Tolerance
  • Education
  • Fentanyl (administration & dosage, adverse effects, pharmacokinetics)
  • Germany
  • Humans
  • Neoplasms (physiopathology)
  • Off-Label Use
  • Opioid-Related Disorders (etiology, prevention & control)
  • Risk Factors
  • Societies, Medical

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: